<DOC>
	<DOCNO>NCT01402050</DOCNO>
	<brief_summary>OBJECTIVE : To assess efficacy transcervical Foley catheter compare control release prostaglandin ( Cervidil™ ) cervical ripen term near term woman present labor induction . HYPOTHESIS : In term near term woman present labor induction , transcervical Foley catheter decrease mean time induction delivery six hour compare control release prostaglandin ( Cervidil™ ) .</brief_summary>
	<brief_title>Foley Catheter Versus Cervidil Induction Labor Term</brief_title>
	<detailed_description>BACKGROUND : Induction labor perform 25 % woman present delivery Banner Good Samaritan Medical Center ( 1 ) . The commonality labor induction local issue . The national cesarean rate rise 31.1 % , represent 50 % increase since 1996 ( 2 ) . Part reason increase cesarean delivery rate pervasive use labor induction . This risk mitigate use cervical ripening agent cervix unfavorable induction . Both pharmacological ( prostaglandin analogue ) ripen agent mechanical method utilized , single method show offer significant advantage method . Many center , include , several different method available , since ripen method may one unique contraindication use labor induction . One emerge modality cervical ripen labor induction transcervical Foley balloon catheter placement , think operate mechanical dilation cervix . The modality become popular part due efficacy , safety low cost . The popular method labor induction Banner Good Samaritan Medical Center control release prostaglandin application ( Cervidil™ ) . This modality expensive may require one dose , thus increase duration labor induction hospital cost . A thorough literature search perform PubMed search term `` foley '' `` labor induction '' `` prostaglandin E2 vaginal insert '' 1972 2009 date randomize trial compare efficacy two modality labor induction . Additionally , clinical trials.gov site ( www.clinicaltrials.gov ) search active previously complete study Cervidil™ compare transcervical Foley balloon labor induction . Therefore , propose randomize controlled clinical trial evaluate comparative efficacy two modality cervical ripen labor induction term near term woman . METHODOLOGY : All HIPAA GCP regulation follow IRB approval obtain . This randomize controlled trial conduct Banner Good Samaritan Medical Center ( BGSMC ) Banner Desert Medical Center ( BDMC ) begin February 1 , 2010 continue approximately 330 patient enrol . Patients allocate online randomization system either transcervical Foley catheter control release prostaglandin ( Cervidil™ ) 1:1 ratio . The Foley catheter use 30cc/24 F. The Foley bulb place cervix balloon fill water apply pressure cervix order mechanical dilatation occur . After Foley catheter place , RN check ( gently tug ) placement catheter every 2 hour dislodge . Foley catheter remove either spontaneous expulsion 12 hour expel . If patient randomize controlled release prostaglandin ( Cervidil™ ) arm , control release prostaglandin ( Cervidil™ ) place posterior fornix vagina help ripen , dilate soften cervix remove 12 hour . This medication may repeat additional 12 hour per physician order standard care procedure . The controlled release prostaglandin ( Cervidil™ ) remove sooner tachysystole ( defined 5 uterine contraction 10 minute ) note . After expulsion Foley catheter 12 hour either group , oxytocin start accord hospital 's administration protocol . Otherwise , labor management discretion attend physician . Prophylactic antibiotic administer unless indicate ( GBS prophylaxis , chorioamnionitis develop labor , etc ) . A master subject list generate . Data collection form assign unique patient number start one correlate master list . Data collection form contain patient name , master list number correlate patient ID . The data collection form collect demographic information include date birth statistical analysis . All list keep confidential stored lock condition . The master list destroy study complete final report write . Variables : Outcomes : 1 . Primary : Time start induction delivery 2 . Secondary : A . Proportion patient deliver 12 hour B . Proportion patient deliver 24 hour C. Proportion patient deliver vaginally 12 hour D. Proportion patient deliver vaginally 24 hour E. Chorioamnionitis ( define temperature 38°C high one following : maternal heart rate 100 , baseline fetal heart rate 160 , uterine tenderness , and/or purulent foul-smelling cervical discharge ) F. Endometritis ( define postpartum temperature 38°C high 2 occasion source fever ) G. Overall cesarean rate H. Infection ( Intrapartum , postpartum , cause ) I. Neonatal Information delivery discharge status ( birth weight , apgars , cord pH , anomaly , NICU admission , complication , neonatal death ) J. Postpartum Information ( Endometritis , Uterine tenderness , Maternal HR &gt; 100 BMP , Purulent cervical discharge , wond complication , Ileus/Obstruction , Pneumonia , DVT/PTE ( heparin treat ) Intraperitoneal hematoma , Intraperitoneal abscess , UTI , Pyelonephritis , Maternal ICU admission , Maternal death ) K. Date time Maternal Neonatal discharge 3 . Predictors : A . Patient Demographics ( date birth , race , height , weight ) B . Vital sign C. Maternal Comorbidities ( Chronic Hypertension , Gestational Hypertension , Diabetes , Obesity BMI ) D. Induction Indications ( Abnormal Antepartum Testing , Prior pregnancy , mode delivery , Pre-eclampsia , &gt; 41 week gestation , Group Beta Strep status E. Physical Exam ( Sterile vaginal exam , Membrane status ) F. Study medication/device information ( time administration , removal , success placement ) G. Other induction medication ( indicate ) H. Intrapartum antibiotic ( yes , reason administration ) I . Delivery data ( date , time , mode delivery ) STATISTICAL ANALYSIS : Descriptive statistic use , continuous variable report mean standard deviation categorical variable percentage . T-tests use analyze continuous variable Chi square test categorical variable . Linear regression use determine predictor primary outcome , logistic regression categorical outcome . A two-tailed p &lt; 0.05 consider significant . SAMPLE SIZE CALCULATION : From review available literature evaluate two modalites labor induction ( separate study ) , make follow assumption power calculation : 1 . The mean time delivery Cervidil group 24 hour . 2 . The standard deviation time delivery group 15 hour . 3 . A clinically significant decrease time delivery Foley group 6 hour ( mean 18 hour ) . With alpha 0.05 1-beta 0.90 , sample size 264 ( 132 group ) need . Allowing 20 % cesarean delivery rate , separate analysis perform patient deliver vaginally , total number woman need enrolled 330 . INTERIM DATA ANALYSIS : Because novel nature comparative induction regimen , interim analysis futility analysis purse first 100 study patient enrol . The futility analysis help direct trial progress . A Data Safety Monitoring Board ( DSMB ) place start study . The DSMB comprise independent obstetrician-gynecologist , statistician bioethicist . It regularly review SAE 's . It also conduct interim analysis 100 subject delivery . Using O'Brien-Fleming method , p value stop study due superiority 0.0051 . At final analysis , remain alpha determine superiority 0.0477 . For futility analysis , 100 subject vaginal delivery , conditional power calculate . If conditional power &lt; 0.20 , study halt due futility .</detailed_description>
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>1 . Cervix &lt; 3 cm dilate . If 2cm dilate , must &lt; 80 % efface . 2 . Gestational age ≥ 36 week best obstetric estimate , clinical management decision delivery . 3 . Singleton gestation 4 . Cephalic presentation 1 . Regular uterine contraction ( frequent every 5 minute ) 2 . PROM 3 . Prior transverse uterine incision obstetric contraindication labor 4 . Fever ( define temperature 38°C high ) 5 . Lethal fetal anomaly ( Labor induction perform , plan fetal heart rate monitor cesarean delivery fetal indication . ) 6 . Fetal death 7 . Placenta previa 8 . Suspected placental abruption undiagnosed bleed characterize `` spot '' 9 . Nonreassuring fetal heart rate pattern 10 . HIV</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Time start induction delivery</keyword>
</DOC>